Digest Network Come funziona
Digest / Comunicato

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2025

Compatibilità
Salva(0)
Condividi
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2025
Materiali Allegati (1)

20094_164011_2026_oneinfo.pdf

Scarica Press Kit ->
Recapiti

Comunicati correlati

05/08/2025
Finanza
Risparmio/Affari personali
Fondi di investimento
Industria
Growing revenue Adjusted EBITDA was €21.6 million, +35%, and margins for 16.8%
Fonte
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Emittente
1INFO
Scopri affinità
0
06/11/2025
Finanza
Risparmio/Affari personali
Fondi di investimento
Industria
Fine Foods confirms growth trajectory: revenue +7%, Adjusted EBITDA was €30.5 million (+30.2%) and Adjusted EBITDA Margin 16.1%
Fonte
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Emittente
1INFO
Scopri affinità
0
13/03/2025
Finanza
Risparmio/Affari personali
Fondi di investimento
Industria
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2024.
Fonte
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Emittente
1INFO
Scopri affinità
0